Firazyr Articles
FDA advisory panel backs approval of Shire’s Firazyr for HAE; Replagal site cleared by EMA
27 June 2011
US FDA advisory panel says no to Novartis gout drug Ilaris; agency backs safety of Shire’s Firazyr
22 June 2011
Shire says 2nd-qtr 2010 revenues rose 35% and EPS leapt 71%; updates on Firazyr; Movetis’ Resolor cleared in Switzerland
5 August 2010
Showing 1-7 of 7 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
